Serotonergic functions in man.
Abundant preclinical evidence suggests that serotonin-containing neural systems may participate in the regulation of both extrapyramidal and neuroendocrine function. In an attempt to examine these possibilities in man, patients with various neurologic disorders received drugs believed to facilitate or inhibit serotonergic function. Extrapyramidal signs in patients with parkinsonism or Huntington's disease showed no consistent change with L-tryptophan or parachlorophenylalanine. Unexpectedly, L-5-hydroxytryptophan, given in combination with a peripheral decarboxylase inhibitor, caused a worsening of parkinsonian akinesia and rigidity. Fenfluramine, at doses which appeared to diminish central serotonin but not dopamine turnover, had no consistent effect on the severity of involuntary movements in patients with Huntington's chorea, but did produce a significant rise in plasma prolactin.
D000818:Animals; D001519:Behavior / Q000187:drug effects; D004702:Endocrine Glands / Q000502:physiology; D005116:Extrapyramidal Tracts / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D006801:Humans; D012701:Serotonin / Q000502:physiology*
D012701:Serotonin